Nanostructures can overcome drug efflux mechanisms by inhibiting the function of P-glycoprotein (P-gp), preventing it from pumping anticancer drugs out of cancer cells, thereby increasing the accumulation of drugs within cancer cells (69). Here, PGP is linked to cancer.